Skip to content

Stereotactic MRI Based Image Guidance for the Treatment of Vascular Malformations - a Pilot Study

Stereotactic MRI Based Image Guidance for the Treatment of Vascular Malformations - a Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02991352
Acronym
SIGVaM
Enrollment
10
Registered
2016-12-13
Start date
2017-03-21
Completion date
2017-11-29
Last updated
2017-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Malformations

Keywords

Vascular Malformations, Image Guidance

Brief summary

Treatment of vascular malformations requires the placement of a needle within anatomically non well defined, pathological vessels, which may be as small as 1 mm, with the current state of the art relying exclusively on two dimensional fluoroscopy images for guidance. The investigators hypothesize that the combination of stereotactic image guidance with existing targeting methods will result in faster and more reproducible needle placements.

Detailed description

This prospective study aims to investigate the feasibility of the utilization of stereotactic image guidance technology for the needle based percutaneous treatment of peripheral vascular malformations. The specific device to be utilized is the CAS-One IR system, CE marked for use with needle based procedures in combination with medical image data including MRI data, as required by this study. Utilizing feedback from the stereotactic image guidance system, the interventionalist will attempt to place the needle within the malformation. The position and orientation of the needle relative to the anatomy will be displayed on 2D slices from the MRI, as well as relative to a 3D volume rendering of the patient anatomy constructed from MRI data. The position of the needle relative to the desired position within the malformation will be evaluated utilizing fluoroscopy. If necessary the position of the needle will be adjusted, this adjustment can be performed utilizing navigated feedback or standard fluoroscopy feedback at the discretion of the physician. The final position of the needle will be confirmed on intra-operative DSA imaging and the sclerosant will be applied according to standard clinical protocols. This single-centre pilot study will involve a total of 10 patients suffering from peripheral vascular malformations. Only non-emergency adult patients will be considered for inclusion in this trial. Inclusion will be at the discretion of the treating physician and patient. As the study is designed as a pilot trial, no comparator is considered and no blinding performed. The trial will be performed over a period of nine months.

Interventions

DEVICEImage guided needle placement

Stereotactic MRI based image guidance to aid in the placement of percutaneous needles into vascular malformations using a CE marked navigation system (CAS-One IR, CAScination AG)

Sponsors

University of Bern
CollaboratorOTHER
Insel Gruppe AG, University Hospital Bern
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with venous or mixed venous-lymphatic malformation * Patients which are regular scheduled for a percutaneous treatment of a vascular malformation * Informed Consent as documented by signature

Exclusion criteria

* Age \< 18 years

Design outcomes

Primary

MeasureTime frameDescription
Time to reach the targetDuring the intervention (duration approx. 90 minutes on average)Time from start of targeting to alcohol embolization in minutes

Secondary

MeasureTime frameDescription
Reason to change to standard approachDuring the intervention (duration approx. 90 minutes on average)Asked by the investigator
System Usability Score (SUS)Directly after the intervention (60 minutes afterwards at the latest)Filled out by the interventionalist
Number of attemptsDuring the intervention (duration approx. 90 minutes on average)Defined as number of skin punctures, counted by the investigator
Radiation doseDuring the intervention (duration approx. 90 minutes on average)Measured by the C-arm imaging device in μGym²
Contrast agent volumeDuring the intervention (duration approx. 90 minutes on average)Measured by the nurses in milliliter
Radiation timeDuring the intervention (duration approx. 90 minutes on average)Measured by the C-arm imaging device in seconds

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026